BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37895245)

  • 1. Role of RNA Alternative Splicing in T Cell Function and Disease.
    Banerjee S; Galarza-Muñoz G; Garcia-Blanco MA
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA structures in alternative splicing and back-splicing.
    Xu B; Meng Y; Jin Y
    Wiley Interdiscip Rev RNA; 2021 Jan; 12(1):e1626. PubMed ID: 32929887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA structure and the mechanisms of alternative splicing.
    McManus CJ; Graveley BR
    Curr Opin Genet Dev; 2011 Aug; 21(4):373-9. PubMed ID: 21530232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A progress toward research on alternative splicing of genes in tumor cells].
    Zhou ZR; Sun KL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):177-80. PubMed ID: 16604490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.
    Peng Q; Zhou Y; Oyang L; Wu N; Tang Y; Su M; Luo X; Wang Y; Sheng X; Ma J; Liao Q
    Mol Ther; 2022 Mar; 30(3):1018-1035. PubMed ID: 34793975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Splicing of Pre-mRNA in the Control of Immune Activity.
    Su Z; Huang D
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
    Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
    Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
    PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
    Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
    Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of regulated pre-mRNA splicing in the immune system.
    Lynch KW
    Nat Rev Immunol; 2004 Dec; 4(12):931-40. PubMed ID: 15573128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.
    Martinez NM; Lynch KW
    Immunol Rev; 2013 May; 253(1):216-36. PubMed ID: 23550649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Alternative Splicing in Regulating Host Response to Viral Infection.
    Liao KC; Garcia-Blanco MA
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.
    Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y
    BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Expression Map of the Arabidopsis Root Reveals Alternative Splicing and lincRNA Regulation.
    Li S; Yamada M; Han X; Ohler U; Benfey PN
    Dev Cell; 2016 Nov; 39(4):508-522. PubMed ID: 27840108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation of pre-mRNA alternative splicing in human populations.
    Lu ZX; Jiang P; Xing Y
    Wiley Interdiscip Rev RNA; 2012; 3(4):581-92. PubMed ID: 22095823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
    Mourich DV; Iversen PL
    Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease.
    Ren P; Lu L; Cai S; Chen J; Lin W; Han F
    Front Immunol; 2021; 12():713540. PubMed ID: 34484216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma.
    Wu Q; Feng L; Wang Y; Mao Y; Di X; Zhang K; Cheng S; Xiao T
    Signal Transduct Target Ther; 2022 Aug; 7(1):270. PubMed ID: 35989380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing isoforms in health and disease.
    Kim HK; Pham MHC; Ko KS; Rhee BD; Han J
    Pflugers Arch; 2018 Jul; 470(7):995-1016. PubMed ID: 29536164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.